| Roche Pharma (Schweiz) AG - Cellcept, Pulver zur Herstellung einer Suspension zum Einnehmen |
| 54701 | | 01 | | Cellcept | | Pulver zur Herstellung einer Suspension zum Einnehmen | | L04AA06 | | Mycophenolic Acid | | 14.06.1999 | | |
|
| Composition |
| mofetili mycophenolas 200 mg, lecithinum ex soja, arom.: vanillinum et alia, aspartamum, sorbitolum, conserv.: E 218, excipiens ad pulverem corresp. suspensio reconstituta 1 ml. |
| Packungsbestandteile |
| Pulver zur Herstellung einer Suspension zum Einnehmen | | | | | | | | Active Agent | Dose |
|---|
| Mofetil Mycophenolate | 200 mg |
| | BAG: Active Agent | Dose |
|---|
| Mofetil Mycophenolate | 200 mg |
| | | | Inactive agents | | additional_information |
|---|
| Alia | | | | Aspartame | | | | E 218 | | conserv. | | Lecithinum ex Soja | | | | Sorbitol | | | | Vanilline | | arom. |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 012 | Flasche(n) à 35 g | 148.18 | 177.55 | B | SL | Yes |
|
